Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application

  • Xi Liu
  • Lei Lei
  • Jing-Wen Hou
  • Mu-Fei Tang
  • Sheng-Rong Guo
  • Zhong-Min Wang
  • Ke-Min Chen


The ethylene vinyl acetate copolymer (EVA)/Poly (lactic acid) (PLA) blend and EVA/Poly (ethylene glycol) (PEG) blend were applied as the drug carrier materials for a bi-layer drug-loaded stent coating film, which consisted of a paclitaxel (PTX)-loaded layer and a drug-free EVA layer. The changes of weight and appearance of the drug-free polymeric blend films with increasing time were examined by X-ray diffraction analysis (XRD), gel permeation chromatography (GPC) tests and scanning electronic microscopy (SEM), and the results showed the degradation of PLA and the leaching of PEG from the films. The effects of PLA, PEG and drug contents on in vitro drug release were investigated, and the results demonstrated that the addition of PLA promoted the drug release while the addition of PEG almost did not. Franz cells diffusion test results indicated that the bi-layer structure successfully endowed the stent coating with the release of drug in a unidirectional fashion. The release profiles of films incorporated PTX and the mechanical performance of the film could be customized by readily adjusting the contents of the blend components. Therefore, the polymeric blends could be useful drug carrier materials for drug-loaded stent coating capable of releasing drug in a highly tunable manner.


Drug Release Coating Film Maximum Tensile Strength Ethylene Vinyl Acetate Ethylene Vinyl Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work was supported by National Natural Science Foundation of China (NSFC) (30872554, 81071244), Shanghai Science and Technology Committee (1052nm01000, 10441902000) and the Key program of Shanghai Municipal Education Committee (09ZZ24). The authors would like to thank Instrumental Analysis Center of Shanghai Jiao Tong University for their technical support.


  1. 1.
    Lei L, Liu X, Guo S, Tang M, Cheng L, Tian L. 5-fluorouracil-loaded multilayered films for drug controlled releasing stent application: drug release, microstructure, and ex vivo permeation behaviors. J Control Release. 2010;146(1):45–53. doi: 10.1016/j.jconrel.2010.05.017.CrossRefGoogle Scholar
  2. 2.
    Kolachalama VB, Tzafriri AR, Arifin DY, Edelman ER. Luminal flow patterns dictate arterial drug deposition in stent-based delivery. J Control Release. 2009;133(1):24–30. doi: 10.1016/j.jconrel.2008.09.075.CrossRefGoogle Scholar
  3. 3.
    Guildford A, Colombo P, Bruschi G, Bonacina E, Klugmann S, Santin M. Direct comparison of the short-term clinical performance of z guidant and taxus stents. Int J Cardiol. In Press. doi: 10.1016/j.ijcard.2008.12.161.
  4. 4.
    Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, et al. Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107(1):38–42. doi: 10.1161/01.cir.0000047700.58683.a1.CrossRefGoogle Scholar
  5. 5.
    Unger F, Westedt U, Hanefeld P, Wombacher R, Zimmermann S, Greiner A, et al. Poly(ethylene carbonate): a thermoelastic and biodegradable biomaterial for drug eluting stent coatings? J Control Release. 2007;117(3):312–21. doi: 10.1016/j.jconrel.2006.11.003.CrossRefGoogle Scholar
  6. 6.
    Pan CJ, Tang JJ, Weng YJ, Wang J, Huang N. Preparation and characterization of rapamycin-loaded plga coating stent. J Mater Sci Mater Med. 2007;18(11):2193–8. doi: 10.1007/s10856-007-3075-9.CrossRefGoogle Scholar
  7. 7.
    Perin EC. Choosing a drug-eluting stent: a comparison between cypher and taxus. Rev Cardiovasc Med. 2005;6(Suppl 1):S13–21.Google Scholar
  8. 8.
    Xu ZH, Gu WW, Huang J, Sui H, Zhou ZH, Yang YX, et al. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int J Pharm. 2005;288(2):361–8. doi: 10.1016/j.ijpharm.2004.10.009.CrossRefGoogle Scholar
  9. 9.
    Shi RW, Burt HM. Amphiphilic dextran-graft-poly(epsilon-caprolactone) films for the controlled release of paclitaxel. Int J Pharm. 2004;271(1–2):167–79. doi: 10.1016/j.ijpharm.2003.11.005.CrossRefGoogle Scholar
  10. 10.
    Suh HR, Jeong BM, Rathi R, Kim SW. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres. J Biomed Mater Res. 1998;42(2):331–8.CrossRefGoogle Scholar
  11. 11.
    Drachman DE, Edelman ER, Seifert P, Groothuis AR, Bornstein DA, Kamath KR, et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol. 2000;36(7):2325–32.CrossRefGoogle Scholar
  12. 12.
    Jackson JK, Skinner KC, Burgess L, Sun T, Hunter WL, Burt HM. Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharm Res. 2002;19(4):411–7.CrossRefGoogle Scholar
  13. 13.
    Kalachandra S, Lin DM, Stejskal EO, Prakki A, Offenbacher S. Drug release from cast films of ethylene vinyl acetate (eva) copolymer: stability of drugs by h-1 nmr and solid state c-13 cp/mas nmr. J Mater Sci Mater Med. 2005;16(7):597–605.CrossRefGoogle Scholar
  14. 14.
    Costantini LC, Kleppner SR, McDonough J, Azar MR, Patel R. Implantable technology for long-term delivery of nalmefene for treatment of alcoholism. Int J Pharm. 2004;283(1–2):35–44. doi: 10.1016/j.ijpharm.2004.05.034.CrossRefGoogle Scholar
  15. 15.
    Guo Q, Guo S, Wang Z. A type of esophageal stent coating composed of one 5-fluorouracil-containing eva layer and one drug-free protective layer: In vitro release, permeation and mechanical properties. J Control Release. 2007;118(3):318–24. doi: 10.1016/j.jconrel.2006.12.030.CrossRefGoogle Scholar
  16. 16.
    Ramadevi A, Padmavathy T, Stigall G, Paquette D, Kalachandra S. Eva copolymer matrix for intra-oral delivery of antimicrobial and antiviral agents. J Mater Sci Mater Med. 2008;19(2):721–7. doi: 10.1007/s10856-007-3109-3.CrossRefGoogle Scholar
  17. 17.
    Kalachandra S, Lin DM, Offenbacher S. Controlled drug release for oral condition by a novel device based on ethylene vinyl acetate (eva) copolymer. J Mater Sci Mater Med. 2002;13(1):53–8.CrossRefGoogle Scholar
  18. 18.
    Cho CW, Choi JS, Shin SC. Physicochemical characteristics of quinupramine in the eva matrix. Int J Pharm. 2006;320(1–2):1–3. doi: 10.1016/j.ijpharm.2006.06.016.CrossRefGoogle Scholar
  19. 19.
    Moly KA, Radusch HJ, Androsh R, Bhagawan SS, Thomas S. Nonisothermal crystallisation, melting behavior and wide angle x-ray scattering investigations on linear low density polyethylene (lldpe)/ethylene vinyl acetate (eva) blends: effects of compatibilisation and dynamic crosslinking. Eur Polym J. 2005;41(6):1410–9. doi: 10.1016/j.eurpolymj.2004.10.016.CrossRefGoogle Scholar
  20. 20.
    Chen CC, Chueh JY, Tseng H, Huang HM, Lee SY. Preparation and characterization of biodegradable pla polymeric blends. Biomaterials. 2003;24(7):1167–73.CrossRefGoogle Scholar
  21. 21.
    Cheng L, Lei L, Guo SR. In vitro and in vivo evaluation of praziquantel loaded implants based on peg/pcl blends. Int J Pharm. 2010;387(1–2):129–38. doi: 10.1016/j.ijpharm.2009.12.010.CrossRefGoogle Scholar
  22. 22.
    Cavalcanti LP, Konovalov O, Haas H. X-ray diffraction from paclitaxel-loaded zwitterionic and cationic model membranes. Chem Phys Lipids. 2007;150:58–65. doi: 10.1016/j.chemphyslip.2007.06.219.CrossRefGoogle Scholar
  23. 23.
    Cheng L, Guo S, Wu W. Characterization and in vitro release of praziquantel from poly([var epsilon]-caprolactone) implants. Int J Pharm. 2009;377(1–2):112–9. doi: 10.1016/j.ijpharm.2009.05.007 CrossRefGoogle Scholar
  24. 24.
    Miyajima M, Koshika A, Okada J, Ikeda M, Nishimura K. Effect of polymer crystallinity on papaverine release from poly (l-lactic acid) matrix. J Control Release. 1997;49(2–3):207–15.CrossRefGoogle Scholar
  25. 25.
    Park KI, Xanthos M. A study on the degradation of polylactic acid in the presence of phosphonium ionic liquids. Polym Degrad Stabil. 2009;94(5):834–44. doi: 10.1016/j.polymdegradstab.2009.01.030.CrossRefGoogle Scholar
  26. 26.
    Li C, Cheng L, Zhang Y, Guo S, Wu W. Effects of implant diameter, drug loading and end-capping on praziquantel release from pcl implants. Int J Pharm. 2010;386(1–2):23–9. doi: 10.1016/j.ijpharm.2009.10.046.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Xi Liu
    • 1
  • Lei Lei
    • 1
  • Jing-Wen Hou
    • 1
  • Mu-Fei Tang
    • 1
  • Sheng-Rong Guo
    • 1
  • Zhong-Min Wang
    • 2
  • Ke-Min Chen
    • 3
  1. 1.School of PharmacyShanghai Jiao Tong UniversityShanghaiChina
  2. 2.Department of RadiologyShanghai Ruijin Hospital Luwan BranchShanghaiChina
  3. 3.Department of RadiologyShanghai Ruijin HospitalShanghaiChina

Personalised recommendations